Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

miR-433 is aberrantly expressed in myeloproliferative neoplasms and suppresses hematopoietic cell growth and differentiation.

Lin X, Rice KL, Buzzai M, Hexner E, Costa FF, Kilpivaara O, Mullally A, Soares MB, Ebert BL, Levine R, Licht JD.

Leukemia. 2013 Feb;27(2):344-52. doi: 10.1038/leu.2012.224. Epub 2012 Aug 6.

PMID:
22864358
2.

Analysis of genomic aberrations and gene expression profiling identifies novel lesions and pathways in myeloproliferative neoplasms.

Rice KL, Lin X, Wolniak K, Ebert BL, Berkofsky-Fessler W, Buzzai M, Sun Y, Xi C, Elkin P, Levine R, Golub T, Gilliland DG, Crispino JD, Licht JD, Zhang W.

Blood Cancer J. 2011 Nov;1(11):e40. doi: 10.1038/bcj.2011.39. Epub 2011 Nov 11.

3.

Transcriptional profiling of polycythemia vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F.

Berkofsky-Fessler W, Buzzai M, Kim MK, Fruchtman S, Najfeld V, Min DJ, Costa FF, Bischof JM, Soares MB, McConnell MJ, Zhang W, Levine R, Gilliland DG, Calogero R, Licht JD.

Clin Cancer Res. 2010 Sep 1;16(17):4339-52. doi: 10.1158/1078-0432.CCR-10-1092. Epub 2010 Jul 2.

4.

New molecular concepts and targets in acute myeloid leukemia.

Buzzai M, Licht JD.

Curr Opin Hematol. 2008 Mar;15(2):82-7. doi: 10.1097/MOH.0b013e3282f3ded0. Review.

PMID:
18300752
5.

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth.

Buzzai M, Jones RG, Amaravadi RK, Lum JJ, DeBerardinis RJ, Zhao F, Viollet B, Thompson CB.

Cancer Res. 2007 Jul 15;67(14):6745-52.

6.

How do cancer cells acquire the fuel needed to support cell growth?

Thompson CB, Bauer DE, Lum JJ, Hatzivassiliou G, Zong WX, Zhao F, Ditsworth D, Buzzai M, Lindsten T.

Cold Spring Harb Symp Quant Biol. 2005;70:357-62.

PMID:
16869772
7.

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint.

Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB.

Mol Cell. 2005 Apr 29;18(3):283-93.

8.

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation.

Buzzai M, Bauer DE, Jones RG, Deberardinis RJ, Hatzivassiliou G, Elstrom RL, Thompson CB.

Oncogene. 2005 Jun 16;24(26):4165-73.

PMID:
15806154
9.

Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth.

Fei P, Wang W, Kim SH, Wang S, Burns TF, Sax JK, Buzzai M, Dicker DT, McKenna WG, Bernhard EJ, El-Deiry WS.

Cancer Cell. 2004 Dec;6(6):597-609.

10.

Akt stimulates aerobic glycolysis in cancer cells.

Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB.

Cancer Res. 2004 Jun 1;64(11):3892-9.

11.
12.

Reduced expression of (alpha)5(beta)1 integrin prevents spreading-dependent cell proliferation.

Davey G, Buzzai M, Assoian RK.

J Cell Sci. 1999 Dec;112 ( Pt 24):4663-72.

13.

cDNA characterization and chromosome mapping of the human GAS2 gene.

Collavin L, Buzzai M, Saccone S, Bernard L, Federico C, DellaValle G, Brancolini C, Schneider C.

Genomics. 1998 Mar 1;48(2):265-9.

PMID:
9521882

Supplemental Content

Loading ...
Support Center